首页 产品目录 全部产品 2,2'-azanediylbis(1-(6-fluorochroman-2-yl)ethan-1-ol)

2,2'-azanediylbis(1-(6-fluorochroman-2-yl)ethan-1-ol)

2,2'-azanediylbis(1-(6-fluorochroman-2-yl)ethan-1-ol)

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

99200-09-6

英文名称

2,2'-azanediylbis(1-(6-fluorochroman-2-yl)ethan-1-ol)

别名

NEBIVOLOL-D4;1-(6-fluorochroman-2-yl)-2-[[2-(6-fluorochroman-2-yl)-2-hydroxy-ethyl]amino]ethanol;Nibivolol;Nebivolol Impurity 6(rac-Nebivolol (Mixture of Diastereomers));2,2'-azanediylbis(1-(6-fluorochroman-2-yl)ethan-1-ol);rac-Nebivolol (Mixture of Diastereomers);1-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)-2-[[2-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)-2-hydroxyethyl]amino]ethanol;R-65824

标准英文名

2,2'-azanediylbis(1-(6-fluorochroman-2-yl)ethan-1-ol)

分子式

C22H25F2NO4

分子量

405.44

精确分子量

405.18

SMILES

OC(CNCC(O)C1CCC2=C(C=CC(F)=C2)O1)C1CCC2=CC(F)=CC=C2O1

标准SMILES

OC(CNCC(O)C1CCC2=CC(F)=CC=C2O1)C1CCC2C=C(F)C=CC=2O1

用途

Nebivolol is a highly selective, lipophilic β1-adrenergic receptor blocker used as an antihypertensive agent. It exhibits 290-fold greater selectivity for β1-adrenergic receptors over β2-adrenergic receptors, surpassing the specificity of other selective β1-blockers such as atenolol, metoprolol, and bisoprolol. Unlike conventional β-blockers, nebivolol does not cause bronchial or vascular smooth muscle constriction, lacks intrinsic sympathomimetic activity and membrane-stabilizing effects, and shows no affinity for serotonin, dopamine, or α1/α2-adrenergic receptors. A key distinguishing feature of nebivolol is its ability to enhance nitric oxide (NO)-mediated physiological vasodilation, leading to endothelium-dependent coronary artery dilation and protection of cardiomyocytes against singlet oxygen-induced damage. This vasodilatory effect is endothelium-dependent, particularly for the levorotatory enantiomer, and is abolished upon endothelial removal or inhibition of NO synthase by L-NMMA. Clinically administered as a racemic mixture of dextro- and levorotatory enantiomers in approximately equal proportions, nebivolol offers potent antihypertensive efficacy at low doses, convenient once-daily dosing, and a favorable safety profile with minimal adverse effects (e.g., headache, dizziness, fatigue, gastrointestinal disturbances, cough, pruritus, rash)—most of which are transient and rarely lead to treatment discontinuation. It does not cause orthostatic hypotension and seldom precipitates heart failure or severe bradycardia. Thus, nebivolol represents a novel antihypertensive agent that combines potent β1-blockade with NO-mediated vasodilation, providing effective blood pressure control with fewer side effects compared to traditional β-blockers.

InChIKey

KOHIRBRYDXPAMZ-UHFFFAOYSA-N

安全信息

SureRoute逆合成路线

1.  99200-09-6 逆合成路线 1

—
—
ACBLJP355
99200-09-6
来源: SureRoute

2.  99200-09-6 逆合成路线 2

ACCZIU451
563-67-7
—
—
—
—
ACBLJP355
99200-09-6
来源: SureRoute

3.  99200-09-6 逆合成路线 3

—
—
ACBLJP355
99200-09-6
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手